Speakers: Prabhu Arunachalam from Dr. Bali Pulendran’s lab at Stanford University
Original Broadcast date: November 10 2020
This webinar reviews a study that revealed how the immune system goes awry leading to severe disease during SARS-CoV-2 infections. An Olink analysis of inflammatory proteins in the blood of COVID-19 patients identified three novel proteins associated with disease severity (TNFSF14, EN-RAGE, and OSM) which could serve as potential therapeutic targets.
If you have any questions about Olink, please contact us at info@olink.com.